'Nonstop, Relentless, Inspiring': Remembering Pava LaPere's Life of Innovation and Impact Pava Center
Clasp Therapeutics Launches with $150 Million Investment in Pioneering Precision Immuno-oncology Startups
‘Junk DNA’ No More: Johns Hopkins Investigators Develop Method of Identifying Cancers from Repeat Elements of Genetic Code Technologies